State of Michigan Retirement System reduced its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 164,546 shares of the conglomerate's stock after selling 7,800 shares during the quarter. State of Michigan Retirement System's holdings in Danaher were worth $37,668,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Sivia Capital Partners LLC boosted its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP raised its holdings in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock worth $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC raised its holdings in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock worth $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC lifted its position in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock worth $14,957,000 after buying an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC lifted its position in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after buying an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Insider Buying and Selling at Danaher
In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 10.80% of the company's stock.
Trending Headlines about Danaher
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: Guggenheim reiterated a Buy rating on Danaher, supporting demand-side interest from institutional buyers. Guggenheim Reaffirms Buy
- Positive Sentiment: An analyst price-target lift to $232 signals buy-side upside vs. current levels, which can support the stock if investors focus on medium-term earnings guidance. Price Target Raised to $232
- Neutral Sentiment: Danaher priced ~€3.0 billion of euro-denominated senior notes across maturities (2028–2038). This raises liquidity for operations or M&A but increases long-term debt on the balance sheet. Senior Notes Offering
- Neutral Sentiment: Coverage pieces question whether the recent share weakness makes DHR an attractive value play — useful for long-term investors but not an immediate catalyst. Valuation Article
- Negative Sentiment: Danaher agreed to settle shareholder litigation tied to its post‑pandemic outlook for about $172.5M, a direct hit to cash and a reminder of past forecasting issues; that likely pressured sentiment. Settlement Report
- Negative Sentiment: Short interest rose ~17.8% to 8.18M shares as of April 15 (≈1.3% of float; short-interest ratio ~2.5 days), indicating increased speculative/hedged bearish positioning that can amplify downward moves.
- Negative Sentiment: Morgan Stanley trimmed its price target (from $270 to $255), and UBS issued a pessimistic forecast—both moves add analyst-driven downside pressure despite differing target levels. Morgan Stanley PT Cut UBS Forecast
- Negative Sentiment: Analysts/commentary flag Danaher’s Masimo acquisition as adding long-term potential but creating near-term margin and integration pressure, a nearer-term risk to earnings momentum. Masimo Deal Commentary
Danaher Stock Performance
Shares of DHR opened at $177.31 on Monday. The company's 50 day simple moving average is $195.75 and its 200-day simple moving average is $213.96. The firm has a market cap of $125.49 billion, a PE ratio of 34.30, a price-to-earnings-growth ratio of 2.37 and a beta of 0.95. Danaher Corporation has a 12-month low of $175.00 and a 12-month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher's revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.88 EPS. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.43 EPS for the current year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, April 24th. Stockholders of record on Friday, March 27th were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, March 27th. This is a positive change from Danaher's previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher's dividend payout ratio is currently 30.95%.
Wall Street Analyst Weigh In
DHR has been the topic of a number of recent analyst reports. Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Friday. KeyCorp reissued an "overweight" rating on shares of Danaher in a research report on Thursday, January 29th. UBS Group decreased their price objective on shares of Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley dropped their price objective on Danaher from $270.00 to $255.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, Robert W. Baird reduced their target price on Danaher from $251.00 to $249.00 and set an "outperform" rating for the company in a report on Friday, April 17th. Eighteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $240.70.
Check Out Our Latest Stock Analysis on DHR
About Danaher
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
